Clinicians report that early AKT inhibition side effects are manageable, allowing four out of five patients to maintain ...
BET proteins, especially BRD4, drive oncogenic transcription in solid tumours. First‑generation inhibitors (JQ1, molibresib, ...
Recently, ACROBiosystems has officially received the "Material Suitability Confirmation for Regenerative Medicine Products" (Certificate No.: 薬機審長発第47号) from the Pharmaceuticals and Medical Devices ...
Approval is backed by VIKTORIA-1 (PIK3CA wild-type), a global open-label randomized trial of gedatolisib plus fulvestrant ± palbociclib after progression on CDK4/6 therapy and an aromatase inhibitor.
A new review was published in Volume 13 of Oncoscience on May 22, 2026, titled "Adaptor proteins regulating tumor-associated macrophage polarization during cancer progression." ...
Morning Overview on MSN
A targeted drug won approval for a hard-to-treat form of advanced prostate cancer
Men diagnosed with metastatic hormone-sensitive prostate cancer who carry a specific tumor deficiency now have a targeted treatment option after the FDA cleared capivasertib, sold as Truqap, for use ...
Traffic leaves more behind than exhaust. Every mile also grinds away tiny bits of tire rubber, and when one common tire ...
Tech Times on MSN
Sweeteners mixed with antidepressants suppress key gut bacteria, Cambridge study finds
Sweeteners gut bacteria research from Cambridge shows low-calorie sweeteners directly suppress beneficial gut microbes — with ...
Lung cancer remains one of the deadliest malignancies worldwide, with distant metastasis representing the major obstacle to effective treatment and ...
Possible benefits of vitamin B6 include improved mood and memory, and reduced nausea during pregnancy. Older research has shown possible benefits for premenstrual syndrome and reduced risk of heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results